L Ulas Biter1, Michiel M A van Buuren2, Guido H H Mannaerts3, Jan A Apers1, Martin Dunkelgrün1, Guy H E J Vijgen1. 1. Department of Surgery, Franciscus Gasthuis, Kleiweg 500, 3045 PM, Rotterdam, Netherlands. 2. Department of Surgery, Franciscus Gasthuis, Kleiweg 500, 3045 PM, Rotterdam, Netherlands. M.Buuren2@franciscus.nl. 3. Department of Surgery, Tawam Hospital Johns Hopkins, 15258, Al Ain, United Arab Emirates.
Abstract
INTRODUCTION: Bariatric surgery is the only treatment option that achieves sustained weight loss in obese patients and that also has positive effects on obesity-related comorbidities. Laparoscopic sleeve gastrectomy (LSG) seems to achieve equal weight loss as laparoscopic Roux-en-Y gastric bypass (LRYGB), but there is still much debate about the quality of life (QOL) after LSG, mainly concerning the association with gastroesophageal reflux. Our hypothesis is that QOL after LSG is comparable with QOL after LRYGB. MATERIALS AND METHODS:Between February 2013 and February 2014, 150 patients were randomized to undergo either LSG or LRYGB in our clinic. Differences in QOL were compared between groups by using multiple QOL questionnaires at follow-up moments preoperatively and 2 and 12 months after surgery. RESULTS: After 12 months of follow-up, 128 patients had returned the questionnaires. Most QOL questionnaires showed significant improvement in scores between the preoperative moment and after 12 months of follow-up. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) score deteriorated in the LSG group after 2 months, but recovered again after 12 months. After 2 months of follow-up, the mean GerdQ score was 6.95 ± 2.14 in the LSG group versus 5.50 ± 1.49 in the LRYGB group (p < 0.001). After 1 year, the mean GerdQ score was 6.63 ± 2.26 in the LSG group and 5.60 ± 1.07 in the LRYGB group (p = 0.001). CONCLUSION: This randomized controlled trial shows that patients who underwent LSG have significantly higher GerdQ scores at both 2 and 12 months postoperatively than patients who underwent LRYGB, whereas overall QOL did not differ significantly.
RCT Entities:
INTRODUCTION: Bariatric surgery is the only treatment option that achieves sustained weight loss in obesepatients and that also has positive effects on obesity-related comorbidities. Laparoscopic sleeve gastrectomy (LSG) seems to achieve equal weight loss as laparoscopic Roux-en-Y gastric bypass (LRYGB), but there is still much debate about the quality of life (QOL) after LSG, mainly concerning the association with gastroesophageal reflux. Our hypothesis is that QOL after LSG is comparable with QOL after LRYGB. MATERIALS AND METHODS: Between February 2013 and February 2014, 150 patients were randomized to undergo either LSG or LRYGB in our clinic. Differences in QOL were compared between groups by using multiple QOL questionnaires at follow-up moments preoperatively and 2 and 12 months after surgery. RESULTS: After 12 months of follow-up, 128 patients had returned the questionnaires. Most QOL questionnaires showed significant improvement in scores between the preoperative moment and after 12 months of follow-up. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) score deteriorated in the LSG group after 2 months, but recovered again after 12 months. After 2 months of follow-up, the mean GerdQ score was 6.95 ± 2.14 in the LSG group versus 5.50 ± 1.49 in the LRYGB group (p < 0.001). After 1 year, the mean GerdQ score was 6.63 ± 2.26 in the LSG group and 5.60 ± 1.07 in the LRYGB group (p = 0.001). CONCLUSION: This randomized controlled trial shows that patients who underwent LSG have significantly higher GerdQ scores at both 2 and 12 months postoperatively than patients who underwent LRYGB, whereas overall QOL did not differ significantly.
Authors: Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: Fernando Fornari; Carlos A S Madalosso; Ricard Farré; Richard R Gurski; Victor Thiesen; Sidia M Callegari-Jacques Journal: Eur J Gastroenterol Hepatol Date: 2010-04 Impact factor: 2.566
Authors: Ralph P M Gadiot; L Ulas Biter; Stefanie van Mil; Hans F Zengerink; J Apers; Guido H H Mannaerts Journal: Obes Surg Date: 2017-01 Impact factor: 4.129
Authors: Angelo Bustani Loss; Antônio Augusto Peixoto de Souza; Cid Araújo Pitombo; Marcel Milcent; Fernando Athaíde Veloso Madureira Journal: Rev Col Bras Cir Date: 2009-10
Authors: Piotr Major; Maciej Matłok; Michał Pędziwiatr; Marcin Migaczewski; Piotr Budzyński; Maciej Stanek; Michał Kisielewski; Michał Natkaniec; Andrzej Budzyński Journal: Obes Surg Date: 2015-09 Impact factor: 4.129
Authors: Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann Journal: BMJ Date: 2013-10-22
Authors: Astrid Müller; Ross D Crosby; Janine Selle; Alexandra Osterhus; Hinrich Köhler; Julian W Mall; Thorsten Meyer; Martina de Zwaan Journal: Obes Surg Date: 2018-02 Impact factor: 4.129
Authors: Francesco M Carrano; Angelo Iossa; Nicola Di Lorenzo; Gianfranco Silecchia; Katerina-Maria Kontouli; Dimitris Mavridis; Isaias Alarçon; Daniel M Felsenreich; Sergi Sanchez-Cordero; Angelo Di Vincenzo; M Carmen Balagué-Ponz; Rachel L Batterham; Nicole Bouvy; Catalin Copaescu; Dror Dicker; Martin Fried; Daniela Godoroja; David Goitein; Jason C G Halford; Marina Kalogridaki; Maurizio De Luca; Salvador Morales-Conde; Gerhard Prager; Andrea Pucci; Ramon Vilallonga; Iris Zani; Per Olav Vandvik; Stavros A Antoniou Journal: Surg Endosc Date: 2022-01-20 Impact factor: 4.584